Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Apexbio Technology LLC JNJ-38877605 943540-75-8 5mg
SDP

Catalog No. 5000093494
Encompass_Preferred

JNJ-38877605 (CAS 943540-75-8) is an ATP-competitive small molecule inhibitor targeting the catalytic activity of c-Met receptor tyrosine kinase Comparative in vitro kinase profiling demonstrates approximately 600-fold selectivity for c-Met over a panel of around 250 other tyrosine and serine/threonine kinases effectively inhibiting both HGF-stimulated and constitutive c-Met phosphorylation In vivo JNJ-38877605 exhibits complete oral bioavailability across studied species and sustains inhibition of Met phosphorylation for up to 16 hours in tumor xenograft models with tumor growth suppression correlating with the extent of Met inhibition It has further undergone safety and dosing evaluation in patients with advanced or refractory solid tumors

Catalog No. 50-000-93494 Supplier Apexbio Technology LLC Supplier No. A50925
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

JNJ-38877605 (CAS 943540-75-8) is an ATP-competitive small molecule inhibitor targeting the catalytic activity of c-Met receptor tyrosine kinase Comparative in vitro kinase profiling demonstrates approximately 600-fold selectivity for c-Met over a panel of around 250 other tyrosine and serine/threonine kinases effectively inhibiting both HGF-stimulated and constitutive c-Met phosphorylation In vivo JNJ-38877605 exhibits complete oral bioavailability across studied species and sustains inhibition of Met phosphorylation for up to 16 hours in tumor xenograft models with tumor growth suppression correlating with the extent of Met inhibition It has further undergone safety and dosing evaluation in patients with advanced or refractory solid tumors

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.